K2 Energy Begins 6 Month Battery Endurance Experiment.

This is a very exciting opportunity to test the durability of our batteries in this severe climate”

— Scott Stewart

HENDERSON, NV, USA, October 22, 2018 /EINPresswire.com/ — K2 Energy is putting its battery systems to the test in extreme climates once again to prove that when performance matters, K2 Energy is the clear choice. This test will be taking place in glacial region of Greenland. The Company’s batteries have been designed into a Lidar scanning and surveillance system that has been put in place to continuously monitor the Helheim Glacier.

During the experiment, K2 Energy batteries will be run to depletion while powering these systems, once discharged, they will remain dormant through Greenland’s long, dark winter until the spring when the attached solar panels can generate power to charge the batteries and power-up the system remotely. The goal of the experiment is survival of the batteries for 6 months at a [0%] state of charge, K2 Energy is confident that the batteries will be able to continue balancing, charging, and powering this system autonomously for even longer.

“This is a very exciting opportunity to test the durability of our batteries in this severe climate, and a great opportunity to demonstrate how our customers can eliminate current battery maintenance requirements for remote systems.” said Scott Stewart, Senior Firmware Architect at K2 Energy. “We’re eager to see the results in the spring at the end of this six-month experiment.”

Traditional batteries do very poorly in these conditions, with cold temperatures greatly impacting performance or damaging the systems. Costly shipping to remote locations due to extreme weights is an added concern when deploying products. K2 Energy’s battery systems can be up to ⅓ the weight of traditional batteries, and they are an industry leader when assessing performance through a wide range of temperatures.

K2 Energy is a fast-growing global organization with production facilities in China and Las Vegas, NV. The Company provides Lithium Cells, Modules, and Battery Management System Solutions across the Military, Medical, Industrial, Aerospace, and Commercial markets. K2 Energy offers turnkey solutions while utilizing a strong engineering knowledge base encompassing cell, pack and system research, design, development, and manufacturing. K2 Energy is able to optimize battery solutions to achieve customer goals. K2 Energy Lithium Iron Phosphate batteries are used worldwide in many advanced applications and power a variety of electric vehicles. K2 produces both energy-optimized and power-optimized products, which have a multitude of consumer, product, safety, and environmental benefits.

Megan Smith
K2 Energy
702.478.3590
email us here


Source: EIN Presswire

Women's Health Leader Dr. Victoria Mondloch Returns to CUTV News Radio

WAUKESHA, WISCONSIN, UNITED STATES, October 22, 2018 /EINPresswire.com/ — CUTV News Radio announced today it will feature Dr. Victoria Mondloch in a 12-part series hosted by Doug Llewelyn and Jim Masters every Wednesday from September 26th to December 12th at 12pm ET.

Dr. Victoria Mondloch is a practicing physician with over 30 years of experience specializing in women’s health, family medicine and preventive health and wellness. An OBGYN by training, today Dr. Mondloch describes herself as a wellness physician, partnering with her patients to deliver the best healthcare possible.

“We need physicians to empower patients and educate them on the best ways to get healthy, be healthy and stay healthy,” says Dr. Mondloch.

According to Dr. Mondloch, the foundation of health is hormonal balance, which traditional western medicine too often ignores, overlooks or outright dismisses. Dr. Mondloch says hormones should be the first thing we examine.

This is especially important for young adolescent girls entering puberty, but pediatrician offices are not set up to adequately meet the adolescent’s needs. They need to feel not only engaged, but listened to, and above all, educated.

“My shift in approach is that I feel nobody addresses or educates the adolescent,” says Dr. Mondloch. “They are the forgotten females. So many physicians don’t take the time to educate them or their mothers, but who else is going to teach a young girl who has just had her first period about hormones? Where is this teaching going to come from?”

That’s why Dr. Mondloch wrote Blossoming: Becoming a Woman, an owner’s manual for the transition from young adult to womanhood. Blossoming offers mothers and daughters the groundbreaking truth about becoming a woman that they won’t find on the internet.

“I’m putting a face to the science. If your daughter has too little progesterone, that’s why she has crampy periods that are irregular. There are symptoms that go with those symptoms that can be measured, and if you can measure it, you can address it.”

“I want every woman, every mom and their adolescent daughter, to understand that there’s a resource they can go to,” says Dr. Mondloch. “If this book doesn’t help, they can go to their gynecologist, and if the gynecologist doesn’t help, they can contact me directly.”

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Dr. Victoria Mondloch, visit www.victoriajmondlochmdsc.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Acephate Market driven by the significant growth in agriculture industry

Market Research Nest Reports

Market Research Nest Reports

MarketResearchNest.com published an Report on “Global Acephate Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023”.

PUNE, INDIA, October 22, 2018 /EINPresswire.com/ — This report studies the Acephate Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Acephate Market analysis segmented by companies, region, type and applications in the report.

Acephate is an organophosphate foliar insecticide, primarily used to control aphids including resistance species in vegetables and in horticulture. This colorless to white solid is applied on different crops or vegetables (carrots, tomatoes, lettuce, and potatoes) to control pests such as leaf miners, sawflies, thrips, and caterpillars in.

Scope of the Report:
This report studies the Acephate market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acephate market by product type and applications/end industries.

1) Acephate is an organophosphate foliar insecticide, primarily used to control aphids including resistance species in vegetables and in horticulture. This colorless to white solid is applied on different crops or vegetables (carrots, tomatoes, lettuce, and potatoes) to control pests such as leaf miners, sawflies, thrips, and caterpillars in.
2) It is used on food crops, citrus trees, as a seed treatment, on golf courses, and in commercial or institutional facilities. It is also sprayed on golf courses, turf, and horticulture crops.
3) It can either can be mixed as a powder along with the vegetation soil or be sprayed over vegetation. Acephate is sold as a powder, granules, liquids, tablets, and in water-soluble packets. Acephate as a general insecticide has a residual effect of 10-15 days.
4) The worldwide market for Acephate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017.

Inquiry before buying sample copy of Acephate Market Report 2018@
https://www.marketresearchnest.com/report/enquirybuy/455170

Acephate Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Acephate Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Companies, this report covers:
1) Bayer
2) Kenvos Biotech
3) Hubei Sanonda
4) Sinon Chemical
5) Hebei Veyong Bio-Chemical Co. Ltd.
6) Rallis
7) Lianyungang Dongjin Chemical

Market Segment by Regions, regional analysis covers:
1) North America (United States, Canada and Mexico)
2) Europe (Germany, France, UK, Russia and Italy)
3) Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
4) South America (Brazil, Argentina, Colombia)
5) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse full content and In-depth TOC of Acephate Market Report 2018@
https://www.marketresearchnest.com/Global-Acephate-Market-2018-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2023.html

The Acephate Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Market Segment by Type, covers:
1) Powder
2) Granules
3) Liquids
4) Tables
5) Water-soluble packets

Market Segment by Applications, can be divided into:
1) Agriculture
2) Forestry
3) Horticulture
4) Others

Key questions answered in this report
1) What will the Acephate Market Size is in 2023 and what will the growth rate be?
2) What are the key Acephate Market Trends?
3) What is driving this Acephate Market?
4) What are the challenges to Acephate Market Growth?
5) Who are the key vendors in this Acephate Market Space?
6) What are the Acephate Market Opportunities and Threats faced by the key vendors?
7) What are the strengths and weaknesses of the Acephate Market Key Vendor?

Purchase a sample copy of Acephate Market Report 2018 Copy@
https://www.marketresearchnest.com/report/purchase/455170

About us: – MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on industries, organizations, products, and trends.

Mr Jeet
Market Research Nest
1-240-284-8070
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn


Source: EIN Presswire

Dr. Victoria Mondloch Continues to be Featured on CUTV News Radio as a Leader in Women's Health

WAUKESHA, WISCONSIN, UNITED STATES, October 22, 2018 /EINPresswire.com/ — CUTV News Radio proudly continues its 12-part radio series featuring Dr. Victoria Mondloch, every Wednesday at 12pm Eastern, from now until December 12th. Doug Llewelyn and Jim Masters host this exciting and informative series.

Dr. Victoria Mondloch is a practicing physician with over 30 years of experience specializing in women’s health, family medicine and preventive health and wellness. An OBGYN by training, today Dr. Mondloch describes herself as a wellness physician, partnering with her patients to deliver the best healthcare possible.

“We need physicians to empower patients and educate them on the best ways to get healthy, be healthy and stay healthy,” says Dr. Mondloch.

According to Dr. Mondloch, the foundation of health is hormonal balance, which traditional western medicine too often ignores, overlooks or outright dismisses. Dr. Mondloch says hormones should be the first thing we examine.

This is especially important for young adolescent girls entering puberty, but pediatrician offices are not set up to adequately meet the adolescent’s needs. They need to feel not only engaged, but listened to, and above all, educated.

“My shift in approach is that I feel nobody addresses or educates the adolescent,” says Dr. Mondloch. “They are the forgotten females. So many physicians don’t take the time to educate them or their mothers, but who else is going to teach a young girl who has just had her first period about hormones? Where is this teaching going to come from?”

That’s why Dr. Mondloch wrote Blossoming: Becoming a Woman, an owner’s manual for the transition from young adult to womanhood. Blossoming offers mothers and daughters the groundbreaking truth about becoming a woman that they won’t find on the internet.

“I’m putting a face to the science. If your daughter has too little progesterone, that’s why she has crampy periods that are irregular. There are symptoms that go with those symptoms that can be measured, and if you can measure it, you can address it.”

“I want every woman, every mom and their adolescent daughter, to understand that there’s a resource they can go to,” says Dr. Mondloch. “If this book doesn’t help, they can go to their gynecologist, and if the gynecologist doesn’t help, they can contact me directly.”

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Dr. Victoria Mondloch, visit www.victoriajmondlochmdsc.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Frank Hamilton Ph.D. to be Featured on CUTV News Radio

SAINT PETERSBURG, FLORIDA, UNITED STATES, October 22, 2018 /EINPresswire.com/ — Community cats roam the streets are in every part of the world trying to survive. They are labeled as “ferals,” “strays,” “free roaming cats” or “community cats” when they have had the misfortune of ending up on the streets through human negligence. A staggering amount winds up in kill shelters where they are euthanized. We as a nation have been catching and killing for almost 100 years and have not solved or changed the situation. It is in fact it’s the definition of insanity. It is morally and fiscally wrong. Fortunately, there are millions of kind hearted and compassionate people trying to help these cats by becoming dedicated caretakers providing them with outside shelter, vet care, food, and water. One man is making an even stronger difference to remedy the problem for good.

Frank Hamilton is an Associate Professor of Management at Eckerd College and a dedicated Animal Welfare advocate. He became aware of the challenge of these animals back in the 1990’s and has worked to develop and implement nonlethal solutions.

“What animal control should do is provide low cost spay/neuter, trap, neuter, return (TNR), or return to field (RTF)” says Frank. “When you trap neighborhood cats and put them down what happens? New cats move in so it’s a vicious cycle therefore it absolutely benefits cats and the public to sterilize the cats and return them.”

Many people aren’t aware that the government uses our tax dollars to put animals down. Low cost spay/neuter, T.N.R., and RTF are programs that are saving all citizens money. And by fixing cats it will cease them from giving birth outside to thousands of kittens who without homes or caretakers suffer in the streets and continue to roam the neighborhoods. That’s a moral issue solved. No longer will people hear these poor cats fighting outside in heat, they will be calm and less stressed no longer forced to reproduce. It’s the most humane, logical and ethical approach.

“Besides implementing targeted low cost spay/neuter, T.N.R., or RTF, caretakers should be provided with accessible traps and taught how to correctly use them so cats can be trapped safely and brought to a low cost spay neuter facility.”

Aside from having co-founded and directed a spay neuter clinic where he successfully fixed over 100,000 animals; Frank has been conducting studies on community cats. Conclusively, it’s a certainty that spay/neuter is a must to control the animal population and reduce homeless pets who suffer in shelters. To make it more accessible and more affordable spay/neuter clinics need to be where the people are including those with lower income who can’t afford the surgery.

“Dedicated kind hearted caretakers feed and shelter their cat colonies rain or shine every day and night,” says Frank. “So there has to be a network where caretakers can get help in case of emergencies where a cat needs vetting.”

The University of Florida Veterinary School has been running a once a month free clinic for feral cats and last month performed 174 surgeries. Ideally if this service was everywhere it would be a hugely effective start.

“Cats that stay more than a week in shelters get URI or Kennel cough plus it’s highly stressful and wrong to keep them caged,” says Frank. “It was proven that when shelters released cats and did not keep them languishing in these shelters illnesses declined tremendously. Return to field helps animal control so it’s a solution. Euthanasia is not only immoral it’s not solving any problems.”

Educating the public it’s a win win for animals, caretakers, and the entire public!

“Understanding what is going on with the government and with citizens when it comes to community cats is absolutely necessary,” says Frank. “You want animal control to take care of animals not kill them. Advocating for our community cats is what we should wholeheartedly encourage in every part of the world.”

CUTV News Radio will feature Frank Hamilton in an interview with Jim Masters Monday October 22nd at 2 p.m. EST.

Listen to the show on BlogTalkRadio.

If you have any questions for our guest please call (347) 996-3388

Author: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Inmedix CEO to Co-Chair Immuno-autonomics Study Group at 2018 Annual Meeting of the American College of Rheumatology.

Andrew J. Holman, MD, Inmedix CEO & Co-founder, to highlight how linkage between the brain and immune function adversely affects autoimmune disease treatment.

NORMANDY PARK, WA, USA, October 20, 2018 /EINPresswire.com/ — Inmedix, the leader in next-generation heart rate variability (HRV) application as an informative diagnostic tool in autoimmune disease, today announced that CEO & Co-founder, Andrew J. Holman, MD, will co-chair the ACR study group “Immuno-autonomics: Emerging Diagnostic & Therapeutic Advances in Rheumatology”” with Paul-Peter Tak, MD, PhD, Professor of Medicine, Academic Medical Center/University of Amsterdam, and former Chief Immunology Officer & Senior Vice President R&D Pipeline at GlaxoSmithKline (GSK) during ACR/ARHP Annual Meeting 2018, being held October 19-24, 2018 at the McCormick Place Convention Center, Chicago, IL.

Drs. Holman and Tak will be joined by Katherine Thanou, MD, Adjunct Professor of Medicine at the College of Medicine at the University of Oklahoma and Assistant Member of the Oklahoma Medical Research Foundation (OMRF), who will review her groundbreaking research related to immuno-autonomic HRV assessment in patients with systemic lupus erythematosus (SLE). The ACR/ARHP Study Group will be held in Room W196b at 1-2 pm on Monday, October 22, 2018.

Immuno-autonomics is the interface between stress, modulated within the brain by the autonomic nervous system (ANS), and the immune system. In autoimmune disease, the immune system attacks healthy tissues for reasons which remain unclear. Therapy is directed with various immunosuppressive strategies to reduce this inappropriate attack and potential destruction of joints, skin, kidney, brain, etc. (depending on the specific autoimmune disease).

Stress intensifies autoimmune disease, thereby reducing the effectiveness of current immunosuppressive options. This ACR/ARHP study group on immuno-autonomics is the third in the past four years. The lectures emphasize new opportunities to both accurately measure ANS stress and reduce its adverse effects to help rheumatologists restore the lives of patients with autoimmune diseases.

“Immuno-autonomics is a relatively new concept in medicine based on what our patients have been telling us for decades,” says Andrew J Holman, MD, Inmedix CEO, rheumatologist and Clinical Associate Professor of Medicine at the University of Washington. “Stress flares autoimmune disease to make it far less responsive to treatment. Understanding how and why may significantly enhance the way rheumatologists manage and even someday prevent autoimmune diseases.”

About Inmedix, Inc. and its subsidiary, Inmedix UK, Ltd.

Seattle-based biotech/medtech Inmedix, Inc. and its subsidiary Inmedix UK, Ltd. are committed to engaging in world class research to discover innovative solutions for pressing healthcare needs related to the impact of stress, modulated within the brain by the autonomic nervous system (ANS). The Inmedix ANS Neuroscan™ is leading applications of next-generation heart rate variability (HRV) as an informative diagnostic, therapeutic, digital health and health economic tool in autoimmune disease. ANS profile may be the most overlooked element of personalized, precision medicine. Beginning with rheumatoid arthritis (RA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and ankylosing spondylitis (AS) in adults, the company hopes to enhance current therapeutic outcomes through complimentary optimization of individual ANS profile.

Rae Marie Gleason
Education Program Director, Inmedix, Inc.
714-423-4863
email us here


Source: EIN Presswire

Spacebit Technologies Ltd. Disrupts Space Exploration with Distributed Ledger Technology

How can technology bridge the gap between space enthusiasts, governments, professional institutions, and private organizations?

Spacebit is co-creating DLT applications for commercial space with the IOTA protocol and Qubic protocol for AI and outsourced heavy computing.”

— Samuel Reid, VP Development of Spacebit

LONDON, ENGLAND, UNITED KINGDOM, October 20, 2018 /EINPresswire.com/ — What if everyone had the ability to participate in space projects? What would happen if space exploration and travel were to become — democratized? How can technology bridge the gap between space enthusiasts, governments, professional institutions, and private organizations?

Introducing Spacebit: A team of blockchain pioneers, astronauts, entrepreneurs, engineers, and rocket scientists, driven to democratize access to commercial space missions around the earth, the moon, and beyond. Using state of the art blockchain technology, Spacebit will decentralize the way in which these projects are executed and decided so that maximal involvement in the initiatives and mission choices are had by the public.

Spacebit's first blockchain application for the commercial space industry is a decentralized ground communications system associated with satellite communications. The LinkX ground station scheduling system which is currently in beta will integrate into the global communication platform Orbit: Linx. This developing infrastructure will leverage blockchain to unify both public and private organizations around the world with a cohesive decentralized network for engagement with satellite communications.

The data shared between satellite providers and usage companies is a rare and valuable commodity. This decentralized global communication platform aims to become the platform of choice for handling space-related data. By consolidating this type of data into one platform, our technology lends itself opportunities to make technological breakthroughs across a myriad of industries.

When great minds are aligned, profound results are produced. Our decentralized and democratic backbone allows great minds all around the world to collaborate under a shared vision. We are paving a future towards a legitimate crypto economy among space-oriented companies and entrepreneurs. Our use of distributed ledger technology makes this type of economy possible.

In partnership with the Goonhilly Earth Station, Spacebit is building a new ecosystem for ground-based elements in space missions. These elements include radio communication systems, ground networks, and eventually components of mission control. Spacebit will be utilizing Goonhilly's existing network of over 60 dishes to run our pilot projects.

Get involved with Spacebit today by:
Joining their Telegram – https://t.me/spacebitENG
Subscribing to their website – https://spacebit.com/
Follow them on Medium – https://medium.com/@spacebit

Samuel Reid
Spacebit Technologies Ltd.
1-403-818-4830
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Spacebit Founder Pavlo Tanasyuk Tours Goonhilly Earth Station with CEO Ian Jones


Source: EIN Presswire

Miles Clark, Director Of Clinical Research for Clinical Based Research Company, Excited To Be A Part of Waite Enterprise

Waite Enterprise CEO Daniel Waite working closely with Miles Clark to build out the health sector of Corporate Holdings.

DALLAS, TX, USA, October 19, 2018 /EINPresswire.com/ — Clinical Based Research is a successful clinical research organization based in Dallas, TX. The company is currently moving in to the new Waite Enterprise corporate headquarters facilities in Dallas, and is part of Daniel Waite and the company’s leadership’s long term diversification planning. The company is an emerging leader in the clinical studies data sector of the health industry.

“Clinical based research is more than a great company. CBR provides great services in an area of need.” Waite Enterprise CEO Daniel Waite explains. “CBR focuses on post market clinical research as well as phase trials. Clinical Based Research is excited to announce Miles Clark as the director of clinical research. Miles has a background in finance, clinical research and other sectors as well. He has 8 years in the post market clinical research and phase trials. Also several years with a billion dollar hedge fund. He is simply a leader in a strong sector for this company who understands the bigger picture. He is a specialist in his field but he understands the larger aspects of finance and investing and leveraging.

“That is really what we are building here, quality people and leadership that provide great guidance and insight so that we stay ahead of the field. When you boil it down, what is a company anyway but its people? You think of Ford you think of cars and trucks but it started with Henry Ford and his vision. You think of Apple you think of technology devices but it started with Steve Jobs and his vision and drive. We are building a company filled with diverse leadership, expertise and skill sets. So sure we will hold diverse physical assets like gold and Bitcoin and real estate to leverage profits against financial and economic turmoil, but we are adding leaders like Miles and Roberto Saenz and Larry Pickett that are worth more than all the gold and BTC in the universe. Waite Enterprise with visionaries and leaders like Miles is becoming a diverse business leadership and innovation basket. That is the long term goal. Not to just have the gold to cover economic hardships, to have the leaders that can help us fix the economic hardship in the first place. The investments will just buy them the time they need to develop and implement strategies and get to work.”

About Waite Enterprise:

Waite Enterprise (subsidiary of Waite Capital, Inc.) is a diversified holding company with a vast platform of subsidiaries and investments that leverage resources and growth from various sectors, currencies and assorted commodities, from cryptocurrency to real estate to high end vehicles. The company is being developed by Daniel Waite with the intention of ultimately going public, offering a diversified investment platform designed as a basket that provides revenue streams from digital platforms, currencies, and businesses in the construction, healthcare and financial fields.

About Clinical Based Research:

Clinical Based Research is a clinical research organization that focuses on post market clinical research as well as phase trials. The company is headquartered in Dallas, Texas and is expanding throughout the Southwest region of the United States.

don eminizer
Smoulder Pro
717-387-5149
email us here


Source: EIN Presswire

Politics & Profits Promote Poison as Public Policy

Harmful algal blooms are silent killers

This singular solution is only one small part of what needs to be done …. That disaster is the HAB’s and the incestuous relationships between Agra-Business and politicians that are killing us all.”

— Lee Roberts

SARASOTA, FL, USA, October 19, 2018 /EINPresswire.com/ — From Florida to Maine – from Ohio to Idaho and Hawaii – throughout all 50 states, an epidemic continues to kill the environment, wildlife, businesses and us humans. The disaster goes by many names: “Red Tide”, “Harmful Algal Blooms”, “Act of God”, “Natural Disaster” are only a few. All are inaccurate labels.

The phenomena occur in a rainbow of colors, from brownish-yellow to blue-green to a rusty-red. What are often referred to as HAB’s aren’t merely “harmful”, they are deadly. Neither God nor Mother Nature can be held responsible for the overt acts of Agra-Business in concert with the incompetence and negligence of local, state and federal politicians.

To simplify, an HAB is an apolitical colony of billions of microscopic organisms that reproduce in fresh, brackish and saline lakes, swamps, estuaries, rivers, and coastal waters. As water temperatures warm, with a steady diet of nitrogen, phosphates and other man-made nutrients, the algae thrive and suck every molecule of oxygen from their habitat. In a best case scenario “dead zones” occur over 10’s of 1,000’s of square miles wherein all aquatic life is suffocated and washes ashore to decay and stink in the sun.

The worst case, undeniable fact, is that toxins are released into public food and water supplies as well as the air that we and all land-bound creatures breathe. Those poisons do not disappear along with the deaths of micro-bacteria or fish, they continue to destroy and sicken every life form into which they come in contact.

The adverse effects of the pesticides and fertilizers that contaminate essentially all crops, pet and livestock feed are exacerbated retroactively and going forward. But it gets worse. A recent video, Toxic Puzzle, tracks global algae toxicity and links HAB’s to ALS, Alzheimer’s and Parkinson’s diseases.

No matter one’s political affiliation, whether he or she “believes in science”, there exists a symbiotic relationship between governance and campaign contributions. For the reactionary, myopic and naïve, there’s no need to read any further. For those who are capable of critical thought and have the intestinal fortitude to face reality, below are a few specific facts as well as viable solutions.

The technology for identifying, tracking, forecasting and mitigating (if not remedying) the toll of HAB’s has existed for decades and continues to improve. Among an alphabet of local, state and federal agencies, budgets and programs are now designed to accommodate special interests and political expediency. The Environmental Protection Agency (EPA), the Center for Disease Control (CDC), the National Oceanographic and Atmospheric Administration (NOAA) are only fractions that have suffered dramatic budget cuts in conjunction with an agenda of de-regulation.

As a single case study, in the state of Florida, the annual economic losses far exceeds $1 billion in healthcare costs, unemployment, business closures, reductions in tourism, real estate values and related sectors. Rather than any proactive response to address the causes, the administration and lawmakers pushed through a paltry $3 million band-aid grant … about 3/10ths of one percent compared to the HAB damage.

Industry is providing the nutrients and cash necessary to allow toxic tides and elected officials to flourish. In turn, selected contractors and manufacturers receive revenue windfalls and sweetheart deals. Petitions, demonstrations and demands to elected representatives may be cathartic, but have proven to be a (toxic) waste of time.

Increasingly, grass roots movements among consumers and innovations among small businesses in the private sector are achieving the only meaningful results. One of the most promising solutions in combating the systemic disaster is SmartNute. After almost 5 years of dedicated research and development, combined with as much passion and commitment, the organization has created the alternative to deadly run-offs of pesticides, toxic waste and excessive nutrients nurturing the HAB’s that infect our air, water, and food chain.

This singular solution can prove to be vastly more cost-efficient, socially responsible and the most immediate method to produce safe and healthy agricultural products. Co-founder Lee Roberts encourages and solicits innovation and activism from all organizations to reverse the rampant pesticide and HAB toxicity levels.

“This singular solution is only one small part of what needs to be done to finally curb the expanding disaster. That disaster is the HAB’s and the incestuous relationships between Agra-Business and politicians that are killing us all.”

Lee Roberts
SmartNute
941.552.8248
email us here


Source: EIN Presswire

American Gene Technologies Granted FDA Orphan Drug Designation For Phenylketonuria

ROCKVILLE, MD, UNITED STATES, October 18, 2018 /EINPresswire.com/ — American Gene Technologies (AGT), a leading gene and cell therapy company in the discovery and development of lentiviral vector based therapeutics, announces that the U.S. Food and Drug Administration (FDA) received orphan-drug designation #DRU-2018-6572 for the treatment of phenylketonuria (PKU) using its proprietary, lentiviral vector based technology. PKU is a debilitating inherited disease affecting 1 in 13,500 children born in the U.S. Mandatory screening identifies affected children who can be supported with a strict synthetic diet that does not cure disease. If successful, AGT's lentiviral vector approach will provide a permanent cure, improving quality of life for more than 16,000 people living with PKU in the U.S. alone.

“We are pleased to receive this orphan drug designation from the FDA for AGT’s vector technology to treat PKU. Our technology demonstrates promising potential to address an unmet medical need in treating this rare disease,” said Jeff Galvin, CEO and Founder of AGT. “We believe this orphan designation will enable AGT to formally shape and advance its PKU program.”

About American Gene Technologies (AGT):

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including: large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

Website: www.americangene.com

American Gene Technologies Contacts:

C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269
Email: info@americangene.com

Media Contact: Sasha Whitaker, swhitaker@americangene.com
American Gene Technologies
(301) 337-2100
email us here


Source: EIN Presswire